Christopher Kemmerer, PhD
Global Head CMC, Pharmaceutical Development
Dr. Kemmerer leads the chemistry, manufacturing, and controls functions for HUYABIO’s in-licensed drug candidates, leveraging expertise in formulation and process development, scale-up, tech transfer and manufacturing. With over 25 years of drug development experience in the pharmaceutical/biotech industry, he has held roles of increasing levels of responsibility at Merck and Pfizer on the development and manufacture of a broad range of drug products, including Emend®, Nexium® and Pepcid®. Previous biotech startup work included Director, Formulation at Avera and VP, Pharmaceutical Development and Manufacturing at Neothetics, where he led the advancement of central nervous system, irritable bowel syndrome and aesthetic fat reduction drug product candidates. Dr. Kemmerer received his PhD in Pharmaceutical Science at Temple University and BS in Chemistry from Pennsylvania State University.